Internal profit and loss account
| Internal profit and loss account | 1.1.–31.12.2025 | 1.1.–31.12.2024 |
|---|---|---|
| NET TURNOVER | 60 822 659,62 | 57 184 400,28 |
| Variation in stocks of finished goods and in work in progress | -1 241,56 | 201 784,38 |
| Other operational income | 1 577 755,60 | 1 668 428,16 |
| Raw materials and services | ||
| Raw materials and consumables | ||
| Purchases during the financial year | 13 613 731,57 | 12 469 753,93 |
| Variation in stocks | -1 151 678,00 | -428 508,00 |
| External services | 3 243 845,35 | 2 863 318,98 |
| Raw materials and services, total | 15 705 898,92 | 14 904 564,91 |
| Staff expenses | ||
| Wages and salaries | 23 634 038,60 | 23 112 207,37 |
| Social security expenses | ||
| Pension expenses | 4 118 081,14 | 3 904 634,96 |
| Other social security expenses | 705 232,28 | 533 108,87 |
| Staff expenses, total | 28 457 352,02 | 27 549 951,20 |
| Depreciation, amortisation and reduction in value | ||
| Reduction in value | 0,00 | 481 096,91 |
| Depreciation and amortisation according to plan | 3 147 067,91 | 3 597 246,40 |
| Depreciation, amortisation and reduction in value, total | 3 147 067,91 | 4 078 343,31 |
| Other operating expenses | 18 446 939,75 | 18 499 045,78 |
| OPERATING PROFIT/LOSS | -3 358 084,94 | -5 977 292,38 |
| Financial income and expenses | ||
| Interest income and other financial income | 1 725 037,54 | 2 596 661,30 |
| Interest and other financial expenses | -622 695,42 | -53 550,23 |
| Financial income and expenses, total | 1 102 342,12 | 2 543 111,07 |
| Change in value | 2 753 250,75 | 3 364 304,05 |
| PROFIT/LOSS BEFORE APPROPRIATIONS | 497 507,93 | -69 877,26 |
| Taxes | ||
| Blood Service Research Fund | -170 000 | -500 000,00 |
| PROFIT/LOSS FOR THE FINANCIAL YEAR (internal) | 327 507,93 | -569 877,26 |